The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: 0.00 (0.00%)
Spread: 2.00 (0.017%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 12,050.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 2-From drinks to drugs to cars: Global business hit by EU vote

Fri, 24th Jun 2016 15:43

(Adds further details from companies)

By Ben Hirschler and Martinne Geller

LONDON, June 24 (Reuters) - Chief executives from Tokyo toDenver prepared for long-term disruption, job cuts and lowerprofits on Friday after Britain's vote to leave the EuropeanUnion raised widespread fears over economic growth and sentshare prices spinning.

In Britain itself, businesses including aerospace,housebuilders and drugmakers fear a range of difficulties fromslumping demand to new regulatory hurdles as the pound plungedto its lowest level since 1985.

British Airways owner IAG warned that it would nolonger meet its annual profit target and car manufacturersincluding Ford, which employs around 14,000 people in theUnited Kingdom, indicated that it could ultimately lead to jobcuts.

"Ford will take whatever action is needed to ensure that ourEuropean business remains competitive," the company said, addingthat it had not changed its investment plans yet.

World stocks headed for one the biggest slumps on record asinvestors predicted the impact of the narrow 52 vs 48 percentvote for Britain to leave the European Union would damageeconomic confidence across the globe.

The president of Japan's Nippon Steel & Sumitomo Metal, the world's second-largest steelmaker, said the votewas extremely disappointing.

"We are greatly concerned for the negative impact this willhave, not only on Britain and the EU but also on the globaleconomy," said Kosei Shindo.

Those who campaigned for Britain to leave had said a weakerpound could help UK exports, but it will also reduce the valueof foreign companies' UK earnings and raise questions aboutaccess to the EU market.

"This decision will create tremendous uncertainty, whichwill slow economic activity and decision making," said MartinSorrell, the boss of the world's biggest advertising group WPP.

Jaguar Land Rover, Britain's biggest carmaker, has estimatedits annual profit could shrink by 1 billion pounds ($1.4billion) by 2020 if Britain returns to World Trade Organizationrules for trade with Europe.

Shares in the company's owner, India's Tata Motors, fell 8 percent.

IMMEDIATE STEPS

Some businesses signaled an intention to push for asettlement between the UK and the EU that would minimize damageto their business, while others took immediate steps.

"This is a lose-lose result for both Britain and Europe,"said Airbus CEO Thomas Enders. "We will review our UKinvestment strategy, like everybody else will."

Volkmar Denner, CEO of Bosch, said its investment planswould not change, for now, but it was preparing for a weakerBritish currency: "We have significantly raised our hedgingratios in order to counteract a possible depreciation of theBritish pound."

The German appliances maker plans to invest 25 million eurosin Britain this year.

Randstad, the world's second-largest employmentservices company, said it might need to restructure, as in didduring the financial crisis in 2009, to cope with disruption tothe jobs market.

Prime Minister David Cameron, who campaigned for Britain toremain in, said he would resign and leaders in Scotland, whichvoted strongly to stay in Europe, said they would considerholding a referendum to leave the United Kingdom.

Makers of Scotch whisky, who export more than 90 percent ofwhat they produce, fear market access could be jeopardised.

"There are serious issues to resolve in areas of majorimportance to our industry and which require urgent attention,notably the nature of future trade arrangements with both thesingle (European) market and the wider world," said David Frost,chief executive of the Scotch Whisky Association.

Some investors warned of a coming British or even globalrecession as sterling collapsed to lowest since 1985.

Housebuilders Taylor Wimpey, Barratt Developments and Persimmon saw their market values slump bymore than a fifth on fears of a sharp economic downturn.

Bank shares such as Barclays and Credit Suisse also tumbled, as well as domestic retailers like SportsDirect and Marks & Spencers. Meanwhilesafer-haven sectors, like gold miners and tobacco, outperformed.

STERLING HEADACHE

Big swings in sterling will be a headache for someinternational companies, with a fall in the currency hittingprofits earned in Britain.

International companies with sizeable sterling exposureinclude Denver-based Molson Coors, owner of Carlingbeer, which is heavily reliant on the UK.

But for multinationals reporting in sterling, there will bea short-term boost to profits, when expressed in pounds.

Aside from market access, streamlining of regulations withinthe EU has made life simpler.

Pharmaceutical companies, for example, enjoy a one-stop shopin the form of the London-based European Medicines Agency, whichapproves new drugs for all EU countries, while the EU's openairspace deals have fostered a surge in air travel and commonpolicies on agriculture and food safety have allowed forsmoother supply chains.

Companies in those sectors have fretted that Britain outsidethe bloc would disrupt the regulatory landscape.

Ahead of the vote, some British-based multinationals such asDiageo, Unilever and Rolls-Royce hadexpressed their support for "Remain" directly to employees,although most stopped short of this.

Rolls-Royce said on Friday the medium and long-term impactwould depend on the relationships struck by Britain with the EUand the rest of the world.

Government figures show 12.6 percent of Britain's economicoutput is linked to exports to the EU's 27 other members, forwhom only 3.1 percent of output is linked to exports to Britain.And 80 percent of British businesses trading overseas do so withthe EU.

The Confederation of British Industry has estimated therecould be between 550,000 and 950,000 fewer jobs by 2020 in theevent of Brexit.

For banks, a huge concern has been the threat that financialinstitutions based in London could lose their EU "passports", orthe automatic right to sell services across the bloc undersingle low-cost system. That has made bank shares particularlyvolatile in the run-up to the referendum.

Brexit uncertainty has also helped push British merger andacquisition activity this year at its lowest as a proportion ofglobal activity since records began in 1980.

It could also impact large deals already in process, such asAnheuser-Busch InBev's $100 billion-plus takeover ofSABMiller and the $30 billion merger of London StockExchange Group and Deutsche Boerse. ($1 = 0.7428 pounds) (Additional reporting by Kate Holton, Ritsuko Ando, YukaObayashi and Laurence Frost; editing by Keith Weir and PhilippaFletcher)

More News
27 Mar 2024 08:02

LONDON BRIEFING: Diploma makes buy; Astra wins Japan drug approvals

(Alliance News) - Stocks in London opened in a muted fashion on Wednesday, with some unease lingering in equity markets ahead of a US inflation reading later in the week.

Read more
26 Mar 2024 10:18

China to speed up 'new productive forces', vice president says

BEIJING, March 26 (Reuters) - China will accelerate the development of "new productive forces" and bolster stability and security for the global economy, Vice President Han Zheng told an investment forum in Beijing, as the world's no.2 economy seeks to reassure anxious foreign firms.

Read more
25 Mar 2024 12:09

LONDON MARKET MIDDAY: Stocks make tepid start to new week

(Alliance News) - Stock prices in London were down at midday on Monday, giving back some gains from last week, when equities were boosted by central bank decisions and accompanying statements which investors saw as dovish.

Read more
25 Mar 2024 09:04

LONDON MARKET OPEN: FTSE 100 treads water, FTSE 250 declines

(Alliance News) - The FTSE 100 in London traded flat early Monday, while the pound remained below the USD1.26 mark, as Bank of England Governor Andrew Bailey suggested rate cuts may happen soon.

Read more
25 Mar 2024 08:40

TOP NEWS: AstraZeneca wins US approval for rare nervous system disease

(Alliance News) - AstraZeneca PLC on Monday said its Ultomiris treatment has been approved by the US Food & Drug Administration as the first and only long-acting C5 complement inhibitor to treat neuromyelitis optica spectrum disorder in adults.

Read more
25 Mar 2024 07:59

LONDON BRIEFING: AstraZeneca wins US approval, Kingfisher profit down

(Alliance News) - London's FTSE 100 is set to open lower on Monday, giving back some of last week's progress, when equities were boosted by hope of interest rate cuts.

Read more
25 Mar 2024 07:23

AstraZeneca gets FDA approval for Ultomiris treatment

(Sharecast News) - AstraZeneca has announced that its autoimmune disease treatment Ultomiris has been given the green light by US regulators.

Read more
21 Mar 2024 16:43

AstraZeneca's Tagrisso successful in treating lung cancer

(Alliance News) - AstraZeneca PLC on Thursday reported positive findings following a phase III trial of its lung cancer Tagrisso treatment.

Read more
19 Mar 2024 08:56

TOP NEWS: AstraZeneca to buy Fusion in deal worth over USD2 billion

(Alliance News) - AstraZeneca PLC on Tuesday said it will buy Fusion Pharmaceuticals Inc, a Canada-based clinical-stage biopharmaceutical company developing "next-generation" radioconjugates.

Read more
19 Mar 2024 07:05

AstraZeneca to buy US-listed Fusion Phrama for $2bn

(Sharecast News) - AstraZeneca said it had agreed to buy biopharmaceutical company Fusion Pharmaceuticals for up to $2bn.

Read more
18 Mar 2024 16:09

UK dividends calendar - next 7 days

Tuesday 19 March 
Jarvis Securities PLCdividend payment date
Wednesday 20 March 
Virgin Money UK PLCdividend payment date
Thursday 21 March 
abrdn Asia Focus PLCdividend payment date
abrdn Private Equity Opportunities Trust PLCex-dividend payment date
AIB Group PLCex-dividend payment date
Beazley PLCex-dividend payment date
BlackRock World Mining Trust PLCex-dividend payment date
British American Tobacco PLCex-dividend payment date
Chemring Group PLCex-dividend payment date
CLS Holdings PLCex-dividend payment date
Conduit Holdings Ltdex-dividend payment date
Craneware PLCex-dividend payment date
Crest Nicholson Holdings PLCex-dividend payment date
Diverse Income Trust PLCex-dividend payment date
Fonix Mobile PLCex-dividend payment date
FW Thorpe PLCex-dividend payment date
Glanbia PLCex-dividend payment date
GlobalData PLCex-dividend payment date
Globalworth Real Estate Investments Ltdex-dividend payment date
Goodwin PLCex-dividend payment date
Gore Street Energy Storage Fund PLCex-dividend payment date
Hargreaves Services PLCex-dividend payment date
HgCapital Trust PLCex-dividend payment date
Hikma Pharmaceuticals PLCex-dividend payment date
Jardine Matheson Holdings LDex-dividend payment date
London Finance & Investment Group PLCex-dividend payment date
Maven Income & Growth VCT 3 PLCex-dividend payment date
Maven Income & Growth VCT 5 PLCex-dividend payment date
MTI Wireless Edge Ltdex-dividend payment date
Nichols PLCex-dividend payment date
NWF Group PLCex-dividend payment date
Palace Capital PLCex-dividend payment date
Pearson PLCex-dividend payment date
Pembroke VCT B PLCex-dividend payment date
Primorus Investments PLCex-dividend payment date
Schroders PLCex-dividend payment date
Triple Point Energy Transition PLCex-dividend payment date
Tristel PLCex-dividend payment date
VPC Specialty Lending Investments PLCdividend payment date
Friday 22 March 
easyJet PLCdividend payment date
FRP Advisory Group PLCdividend payment date
Gulf Investment Fund PLCdividend payment date
Henderson Opportunities Trust PLCdividend payment date
Hercules Site Services PLCdividend payment date
Impax Asset Management Group PLCdividend payment date
JLEN Environmental Assets Group Ltddividend payment date
JPMorgan Multi-Asset Growth & Income PLCdividend payment date
Mattioli Woods PLCdividend payment date
Mobeus Income & Growth 2 VCT PLCdividend payment date
Mobeus Income & Growth 4 VCT PLCdividend payment date
Ramsdens Holdings PLCdividend payment date
Riverstone Credit Opportunities Income PLCdividend payment date
Ruffer Investment Co Ltddividend payment date
Samuel Heath & Sons PLCdividend payment date
Troy Income & Growth Trust PLCdividend payment date
Unilever PLCdividend payment date
Monday 25 March 
AstraZeneca PLCdividend payment date
Endeavour Mining PLCdividend payment date
Mountview Estates PLCdividend payment date
Shell PLCdividend payment date
  
Comments and questions to newsroom@alliancenews.com
  
A full 14-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
18 Mar 2024 14:08

AstraZenca hails Imfinzi and Lynparza results on endometrial cancer

(Alliance News) - AstraZeneca PLC on Monday reported positive findings following the analysis of results from a phase III probe of its Imfinzi and Lynparza cancer treatments.

Read more
14 Mar 2024 10:01

TOP NEWS: AstraZeneca buys France's Amolyt Pharma for USD1 billion

(Alliance News) - AstraZeneca PLC on Thursday said it has struck a deal to acquire Amolyt Pharma SAS, strengthening its late-stage rare disease pipeline.

Read more
14 Mar 2024 07:52

LONDON BRIEFING: Astra makes USD1.05 billion buy; Halma backs outlook

(Alliance News) - London's FTSE 100 is set to tread water after the opening bell sounds on Thursday, as investors look to a batch of US data to come in the early afternoon.

Read more
14 Mar 2024 07:16

AstraZeneca snaps up rare disease specialist Amolyt for $1.05bn

(Sharecast News) - Biopharma giant AstraZeneca has announced the acquisition of French biotech firm Amolyt Pharma for up to $1.05bn to beef up its late-stage rare disease pipeline.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.